Jim Cramer on Eli Lilly (LLY) after Trump picks RFK Jr. to lead HHS
Enthusiasm for Eli Lilly, the club's holding company, needs to be tempered, at least for now, as Wall Street grapples…
Enthusiasm for Eli Lilly, the club's holding company, needs to be tempered, at least for now, as Wall Street grapples…
Shares of Abbott Laboratories rose on Friday after the Club holding company scored a surprise victory in a trial into…
GE Healthcare's quiet outperformance is becoming harder to ignore, and its new drug used in radiology to improve the diagnosis…
AI technology stocks have been all the rage on Wall Street. But here are some events that could boost other…
Jim Cramer's daily rapid-fire breaks down stocks in the news outside of the CNBC Investing Club portfolio. Oracle: The tech…
Eli Lilly's weight-loss drug Zepbound showed promise as a treatment for sleep apnea, giving investors more confidence to continue owning…
CNBC's Jim Cramer said Tuesday that Elon Musk's revelation that he takes prescription ketamine for depression was brave and “saved…
Vertiv Holdings: The data center equipment maker, whose stock has roughly quadrupled over the past year, issued guidance that fell…
Club holding company Eli Lilly hopes to win approval for its Alzheimer's treatment in the coming weeks, but investors looking…
CNBC's Jim Cramer called General Electric a winner in the industrial sector because of the advances it is making in…